HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression

Mantle cell lymphoma (MCL) is an especially aggressive and highly heterogeneous mature B-cell lymphoma. Heat shock protein 90 (HSP90) is considered an attractive therapeutic target in a variety of cancers, including MCL, but no HSP90 inhibitors have succeeded in the clinical trials to date. Explorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hanqing, Lu, Ziwen, Shi, Xiaofeng, Liu, Lanlan, Zhang, Peishan, Golemis, Erica A., Tu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363837/
https://www.ncbi.nlm.nih.gov/pubmed/34302809
http://dx.doi.org/10.1016/j.jbc.2021.100996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363837/
https://www.ncbi.nlm.nih.gov/pubmed/34302809
http://dx.doi.org/10.1016/j.jbc.2021.100996

Ejemplares similares